(Logo via Johnson & Johnson)

Johnson & Johnson Expands First-of-its-Kind Pediatric HIV Program to Zimbabwe

Originally Published by JNJ

Harare, Zimbabwe, August 29, 2019 – Johnson & Johnson today announced that its Janssen Pharmaceutical Companies has expanded the New Horizons Collaborative to Zimbabwe—a first-of-its-kind integrated approach to improve pediatric HIV care—to ensure that children and adolescents living with HIV in countries with the highest burden of pediatric HIV have access to sustainable, high-quality, and appropriate antiretroviral (ARV) therapy.

Worldwide, approximately 1.8 million children under age 15 have HIV, and almost 90% are living in sub-Saharan Africa (SSA) with 77,000 of those in Zimbabwe. Even with access to ART, rates of treatment success for children and adolescents are consistently lower than those for adults across Africa. Children are more prone to developing drug resistance to first-line therapies with studies showing that most children failing ART have evidence of drug resistance, highlighting the urgent need for follow-on (second- or third-line) treatment regimens to which resistance has not developed.

“We’ve made tremendous progress in delivering HIV therapies to people in developing countries, overall, but we must do better for children.” said Usheema Maraj De Villiers, Senior Director, Global Public Health, Johnson & Johnson. “New Horizons is a collaborative initiative to build awareness, inspire action, and advance learning around the unmet needs of HIV treatment-experienced children and adolescents and we look forward to partnering with Zimbabwe’s Ministry of Health and Child Care on its roll-out in the country.”

As a multi-sector partnership the New Horizons Collaborative aims to improve and scale-up ARV therapy for children and adolescents through increased awareness and research, health systems strengthening, and improved access to HIV medicines through a donation program. Through the program Janssen provides darunavir and etravirine, including child-friendly formulations, free of charge to eligible countries with the clinical capacity and willingness to address second- and third-line pediatric HIV treatment.”

Launched in 2014 the New Horizons Collaborative includes a host of partners including Janssen, the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), Partnership for Supply Chain Management (PFSCM), Imperial Health Sciences (IHS), CIPHER-IAS, The Relevance Network Ltd, and Right to Care. Ministries of Health in SSA and those countries considered to be least developed as defined by the United Nations are invited to partner with the collaborative to improve and scale-up pediatric HIV treatment and improve access to HIV medicines in their countries. Learn more about the program here: http://www.newhorizonshiv.com.

###

Johnson & Johnson’s Commitment to Make HIV History
Johnson & Johnson has a 25-year heritage of working to end the AIDS epidemic. Our Janssen Pharmaceutical Companies have brought eight HIV therapies to market. We are committed to working with our global partners in the quest to #MakeHIVhistory. To achieve this goal, we are working strategically across three key fronts: prevention, treatment and the search for a cure. Specifically, we are:

  • Advancing innovative new HIV prevention tools, including a ‘global vaccine’ in development at our Janssen Pharmaceutical Companies
  • Bringing new, innovative and simpler treatment options from Janssen to children, adolescents and adults living with HIV
  • Exploring novel HIV cure strategies, including the potential role of therapeutic vaccines in achieving a functional cure

Additionally, the Johnson & Johnson Family of Companies collaborates with numerous patient advocacy groups and supports more than 100 philanthropic programs in more than 50 least-developed countries to address the needs of people living with HIV/AIDS.

Latest News

Novartis Chief Medical Officer John Tsai on Balancing Medical Innovations With Patient Needs

Originally published at novartis.com by Elizabeth Dougherty. John Tsai is Novartis’ Head of Global Drug Development and Chief Medical Officer. Novartis Pharmaceuticals is a DiversityInc Hall of Fame company.   John Tsai’s career as a physician, and now as Head of Global Drug Development and Chief Medical Officer for Novartis, had an unlikely…

Montgomery Mayor Steven Reed

City of Montgomery, Alabama Faces $25,000 State Fine for Changing Street Named After a Confederate Leader

Despite a state law designed to “protect” longstanding Confederate monuments and memorials, the city of Montgomery, Alabama, has decided that it would rather incur a fine than continue going on with a city street named after President of the Confederate States from 1861 to 1865, Jefferson Davis. Kim Chandler of…

Global Diversity

Despite Massive Uptick in Global DEI Initiatives, New Study Reveals Real Change in Corporate Workforces Remains Slow 

Even though DEI as a business imperative continues to grow both in the United States and around the world, a new study has found that many business leaders and executives have merely raised awareness of why diversity, equity and inclusion is important — as opposed to actually making meaningful progress…

Novartis Collaborates With Microsoft To Innovate Medicine Through Data and Artificial Intelligence

Originally published on LinkedIn. Novartis Pharmaceuticals is a DiversityInc Hall of Fame company.   “We are not just discoverers. We actually create molecules that have never been made before.” Says Karin Briner, Head of Global Discovery Chemistry at Novartis Institutes for BioMedical Research (NIBR). By collaborating with Microsoft and augmenting the expertise of our…

Mastercard Announces Launch of Crescent City Card Program in Partnership With New Orleans and MoCaFi

Originally published at mastercard.com. Mastercard ranked No. 5 on The DiversityInc Top 50 Companies for Diversity list in 2021.   New Orleans Mayor LaToya Cantrell was joined by executives from Mastercard, Mobility Capital Finance, Inc. (MoCaFi), and Forward Together New Orleans to announce the Crescent City Card Program. The program involves a…

Mastercard on Supporting Inclusive and Sustainable Urban Development by Expanding Its ‘City Possible’ Network

Originally published at mastercard.com. Mastercard ranked No. 5 on The DiversityInc Top 50 Companies for Diversity list in 2021.   Mastercard has continued to expand its support for addressing urban challenges and inequalities, working with city leaders and partners around the world, through the City Possible™ network and capabilities. The unique solutions…

Rep. Ilhan Omar

Colorado Rep. Lauren Boebert Makes Anti-Muslim Comments Against Fellow Rep. Ilhan Omar of Minnesota

Following the horrific example of Rep. Paul Gosar of Arizona, who posted an animated video depicting the killing of his congressional colleague Alexandria Ocasio-Cortez, another member of the House of Representatives has made a similarly vile attack on a co-worker based purely on her religious beliefs. James Anderson of the…

Pinterest app

Pinterest Enacting New Company-Wide DEI Initiatives Following Gender and Race Discrimination Lawsuit

Following a lawsuit led by the General Treasurer of Rhode Island, social media company Pinterest has announced that it will be enacting a series of new diversity, equity and inclusion workplace reforms to settle a recent lawsuit against them. Patrick Anderson of The Providence Journal reported that “the reforms are…